ResearcherUniversity of VirginiaNo recent work listed

Karol A. Szlachta

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4915-4794; OpenAlex author ID A5051220504. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2018: 1 paper

Papers 1

CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response. Co-author DOI 10.1038/s41467-018-06676-2 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Alex D. Michaels · 1 shared paper, 2018 · strength 0.07
- Paper CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response. DOI 10.1038/s41467-018-06676-2 ↗
Turan Tufan · 1 shared paper, 2018 · strength 0.07
- Paper CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response. DOI 10.1038/s41467-018-06676-2 ↗
Mazhar Adli · 1 shared paper, 2018 · strength 0.07
- Paper CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response. DOI 10.1038/s41467-018-06676-2 ↗
Todd W. Bauer · 1 shared paper, 2018 · strength 0.07
- Paper CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response. DOI 10.1038/s41467-018-06676-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.